TITLE
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

ORGANISM
Mus musculus

SUMMARY
We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions

DESIGN
RNA-seq was performed on orthotopic murine primary and metastatic tumor samples using Illumina Hi-Seq 2000 platform

PLATFORM
GPL13112 Illumina HiSeq 2000 (Mus musculus)

CITATIONS
25605014

